The work reported herein was supported by the grants from the National Natural Science Foundation of China(No.81922066,No.81773706,No.81991523,and No.81630099);the Drug Innovation Major Project(No.2018ZX09711001-003-007).
Over the last decade, the roles of β-arrestins in the treatment of neuropsychological diseases have become increasingly appreciated. Fluoxetine is the first selective serotonin reuptake inhibitor developed and is app...